Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Oblimersen (G3139) may help dacarbazine kill more cancer cells by
making tumor cells more sensitive to the drug. It is not yet known if dacarbazine is more
effective with or without oblimersen (G3139).
PURPOSE: Randomized phase III trial to compare the effectiveness of dacarbazine with or
without oblimersen (G3139) in treating patients who have advanced malignant melanoma.